Managing kidney disease with blood-pressure control

Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovasucular events

(2010) Genjiro Kimura et al.   HYPERTENSION RESEARCH

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

(2010) George L Bakris et al.   LANCET

Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease

(2010) Lawrence J. Appel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic Value of Circadian Blood Pressure Variation in Chronic Kidney Disease

(2009) Rajiv Agarwal et al.   AMERICAN JOURNAL OF NEPHROLOGY

Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis

(2009) S. D. Navaneethan et al.   Clinical Journal of the American Society of Nephrology

Blood Pressure–Independent Reduction in Proteinuria and Arterial Stiffness After Acute Endothelin-A Receptor Antagonism in Chronic Kidney Disease

(2009) Neeraj Dhaun et al.   HYPERTENSION

Superior consistency of ambulatory blood pressure monitoring in children: implications for clinical trials

(2009) Charlotte Gimpel et al.   JOURNAL OF HYPERTENSION

Supramaximal Dose of Candesartan in Proteinuric Renal Disease

(2009) E. Burgess et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional Status

(2009) I. de Brito-Ashurst et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Strict Blood-Pressure Control and Progression of Renal Failure in Children

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

(2008) Johannes FE Mann et al.   LANCET

Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy

(2008) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE